Actrapid HM, Injektionslösung

7680446100354 CH-44610 Injektionslösung
Actrapid HM, Injektionslösung
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1 x 10 ml
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/07/2026
Patient information leaflet
Français
11/07/2026
Patient information leaflet
Italien
11/07/2026
Summary of Product Characteristics
Allemand
01/04/2026
Summary of Product Characteristics
Français
01/04/2026
Summary of Product Characteristics
Italien
01/04/2026

Detailed composition

Substance Quantity Type Category
insulinum humanum ADNr solutum
3.5 MG Substance Wirkstoff (Principe actif)
insulinum humanum ADNr solutum
100.0 UI Substance WIIS
glycerolum
- Substance HNIDK
zinci chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
metacresolum
- Substance Konservierungsstoff (Conservateur)
aqua ad iniectabile
- Substance HNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 28.70
Specialties list
Yes
Generic
No
SL addition date: 15/03/1988

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
44610
Drug name
Actrapid HM, Injektionslösung
Galenic form
LSINJ
ATC Code
A10AB01
Authorization status
Z
Dispensing category
B
First authorization
22/08/1986
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
INSULIN Actrapid HM 100 UI/ml flac 10 ml
Description (DE)
INSULIN Actrapid HM 100 IE/ml Durchstf 10 ml
Market launch
22/08/1986
Narcotic (BTM)
No

Other package sizes (1)

None
1 x 10 ml DUR
GTIN: None
Not in V1
Buy us a coffee Explore the data